496 related articles for article (PubMed ID: 9589096)
1. [Native and signal-enhanced power Doppler sonography for characterization of liver lesions].
Strunk H; Stuckmann G; Fröhlich E; Textor J; Wilhelm K; Hortling N; Remig J
Rofo; 1998 Apr; 168(4):344-51. PubMed ID: 9589096
[TBL] [Abstract][Full Text] [Related]
2. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
3. Color doppler ultrasound of liver lesions: signal enhancement after intravenous injection of the ultrasound contrast agent Levovist.
Ernst H; Hahn EG; Balzer T; Schlief R; Heyder N
J Clin Ultrasound; 1996 Jan; 24(1):31-5. PubMed ID: 8655665
[TBL] [Abstract][Full Text] [Related]
4. Sonographic evaluation of focal nodular hyperplasias (FNH) of the liver with a transpulmonary galactose-based contrast agent (Levovist).
Uggowitzer M; Kugler C; Gröll R; Mischinger HJ; Stacher R; Fickert P; Weiglein A
Br J Radiol; 1998 Oct; 71(850):1026-32. PubMed ID: 10211062
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced power Doppler sonography: improved detection of characteristic flow patterns in focal liver lesions.
Hosten N; Puls R; Lemke AJ; Steger W; Zendel W; Zwicker C; Felix R
J Clin Ultrasound; 1999; 27(3):107-15. PubMed ID: 10064407
[TBL] [Abstract][Full Text] [Related]
6. Contrast media-enhanced power Doppler sonography for evaluation of hemangiomas and malignant tumors in the liver.
Karabacakoglu A; Karakose S; Cil AS; Kaya A
J Gastroenterol Hepatol; 2003 Jan; 18(1):92-8. PubMed ID: 12519230
[TBL] [Abstract][Full Text] [Related]
7. Enhanced color flows in hepatic tumors.
Yang CC; Chen CH; Yeh YH
Hepatogastroenterology; 2002; 49(48):1506-9. PubMed ID: 12397719
[TBL] [Abstract][Full Text] [Related]
8. [Focal liver lesions: clinical usefulness of contrast-enhanced ultrasound in the selection of surgical patients].
Bartolotta TV; Sandonato L; Taibbi A; Latteri S; Soresi M; Lombardo G; Genova C; Latteri MA
Chir Ital; 2009; 61(3):295-307. PubMed ID: 19694231
[TBL] [Abstract][Full Text] [Related]
9. Pulse inversion sonography in the early phase of the sonographic contrast agent Levovist: differentiation between benign and malignant focal liver lesions.
von Herbay A; Vogt C; Häussinger D
J Ultrasound Med; 2002 Nov; 21(11):1191-200. PubMed ID: 12418760
[TBL] [Abstract][Full Text] [Related]
10. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced ultrasound with SonoVue: differentiation between benign and malignant focal liver lesions in 317 patients.
von Herbay A; Westendorff J; Gregor M
J Clin Ultrasound; 2010 Jan; 38(1):1-9. PubMed ID: 19790253
[TBL] [Abstract][Full Text] [Related]
12. Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: correlation with angiographic findings.
Fujimoto M; Moriyasu F; Nishikawa K; Nada T; Okuma M
AJR Am J Roentgenol; 1994 Nov; 163(5):1099-104. PubMed ID: 7976882
[TBL] [Abstract][Full Text] [Related]
13. [Value of combined conventional and contrast enhanced sonography in the evaluation of hepatic disorders].
Tranquart F; Bleuzen A; Kissel A
J Radiol; 2004 Jun; 85(6 Pt 1):755-62. PubMed ID: 15243376
[TBL] [Abstract][Full Text] [Related]
14. Possibility of differentiating small hyperechoic liver tumours using contrast-enhanced colour Doppler ultrasonography: a preliminary study.
Tano S; Ueno N; Tomiyama T; Kimura K
Clin Radiol; 1997 Jan; 52(1):41-5. PubMed ID: 9022579
[TBL] [Abstract][Full Text] [Related]
15. Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: preliminary results.
Bertolotto M; Dalla Palma L; Quaia E; Locatelli M
Eur Radiol; 2000; 10(9):1369-76. PubMed ID: 10997422
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced power doppler sonography in detection and differentiation of focal liver lesions.
Genadieva-Dimitrova M; Neskovski M; Popova R; Joksimović N; Trajkovska M; Milosevski M; Serafimoski V
Prilozi; 2005 Aug; 26(1):41-9. PubMed ID: 16118614
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of focal hepatic lesions with ultrasound contrast agents.
Sutherland T; Temple F; Lee WK; Hennessy O
J Clin Ultrasound; 2011 Sep; 39(7):399-407. PubMed ID: 21674510
[TBL] [Abstract][Full Text] [Related]
18. [Color-coded Doppler sonography of primary and secondary liver tumors].
Börner N; Clement T; Herzog P; Kreitner KF; Miltenberger H; Schild H; Meyer J
Ultraschall Med; 1990 Dec; 11(6):274-80. PubMed ID: 1965059
[TBL] [Abstract][Full Text] [Related]
19. [Vascularization patterns in focal liver lesions: comparison of plain and signal-enhanced amplitude-modulated color duplex ultrasonography].
Hosten N; Steger W; Bechstein WO; Zendel WJ; Venz S; Lemke AJ; Weber S; Vogl TJ; Felix R
Rofo; 1997 Jun; 166(6):507-13. PubMed ID: 9273003
[TBL] [Abstract][Full Text] [Related]
20. Value of contrast-enhanced sonography for the characterization of focal hepatic lesions in patients with diffuse liver disease: receiver operating characteristic analysis.
Kim SH; Lee JM; Lee JY; Han JK; An SK; Han CJ; Lee KH; Hwang SS; Choi BI
AJR Am J Roentgenol; 2005 Apr; 184(4):1077-84. PubMed ID: 15788576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
